1. Home
  2. VIVS vs EZRA Comparison

VIVS vs EZRA Comparison

Compare VIVS & EZRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$0.16

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo Reliance Global Group Inc. Common Stock

EZRA

Reliance Global Group Inc. Common Stock

N/A

Current Price

$2.18

Market Cap

1.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VIVS
EZRA
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
1.9M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
VIVS
EZRA
Price
$0.16
$2.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 721.4K
90.1K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 85.79
EPS
★ N/A
N/A
Revenue
$4,603,000.00
★ $12,430,959.00
Revenue This Year
$228,144.28
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.82
N/A
52 Week Low
$0.14
$0.11
52 Week High
$3.40
$15.56

Technical Indicators

Market Signals
Indicator
VIVS
EZRA
Relative Strength Index (RSI) 37.34 44.36
Support Level N/A $2.02
Resistance Level $0.30 $2.63
Average True Range (ATR) 0.02 0.23
MACD 0.00 0.00
Stochastic Oscillator 36.23 45.17

Price Performance

Historical Comparison
VIVS
EZRA

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

About EZRA Reliance Global Group Inc. Common Stock

Reliance Global Group Inc operates as a holding company that acquires, owns, and actively manages insurance and technology-focused businesses. The company focuses on growing by pursuing acquisition strategies initially, and focuses on wholesale and retail insurance agencies. Its primary move is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations. The Company operates as a single operating segment, the Insurance Segment, earning its revenues from insurance commissions.

Share on Social Networks: